Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 21;19(43):7711-8.
doi: 10.3748/wjg.v19.i43.7711.

Dendritic cell co-stimulatory and co-inhibitory markers in chronic HCV: an Egyptian study

Hanan Fouad  1 , Maissa Saeed El Raziky, Rasha Ahmed Abdel Aziz, Dina Sabry, Ghada Mahmoud Abdel Aziz, Manal Ewais, Ahmed Reda Sayed
Affiliations

Dendritic cell co-stimulatory and co-inhibitory markers in chronic HCV: an Egyptian study

Hanan Fouad et al. World J Gastroenterol. .

Abstract

Aim: To assess co-stimulatory and co-inhibitory markers of dendritic cells (DCs) in hepatitis C virus (HCV) infected subjects with and without uremia.

Methods: Three subject groups were included in the study: group 1 involved 50 control subjects, group 2 involved 50 patients with chronic HCV infection and group 3 involved 50 HCV uremic subjects undergoing hemodialysis. CD83, CD86 and CD40 as co-stimulatory markers and PD-L1 as a co-inhibitory marker were assessed in peripheral blood mononuclear cells by real-time polymerase chain reaction. Interleukin-10 (IL-10) and hyaluronic acid (HA) levels were also assessed. All findings were correlated with disease activity, viral load and fibrogenesis.

Results: There was a significant decrease in co-stimulatory markers; CD83, CD86 and CD40 in groups 2 and 3 vs the control group. Co-stimulatory markers were significantly higher in group 3 vs group 2. There was a significant elevation in PD-L1 in both HCV groups vs the control group. PD-L1 was significantly lower in group 3 vs group 2. There was a significant elevation in IL-10 and HA levels in groups 2 and 3, where IL-10 was higher in group 3 and HA was lower in group 3 vs group 2. HA level was significantly correlated with disease activity and fibrosis grade in group 2. IL-10 was significantly correlated with fibrosis grade in group 2. There were significant negative correlations between co-stimulatory markers and viral load in groups 2 and 3, except CD83 in dialysis patients. There was a significant positive correlation between PD-L1 and viral load in both HCV groups.

Conclusion: A significant decrease in DC co-stimulatory markers and a significant increase in a DC co-inhibitory marker were observed in HCV subjects and to a lesser extent in dialysis patients.

Keywords: CD83; CD86, CD40; Dendritic cells; Hemodialysis; Hepatitis C virus; Hyaluronic acid; Interleukin-10; PD-L1; Uremia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relative quantitative gene expression of CD83, CD86, CD40 and PD-L1 in all study subjects expressed as mean ± SD. aP < 0.05 in both hepatitis C virus (HCV) patient groups vs control group; cP < 0.05 in the HCV patient group vs HCV uremic patients on hemodialysis.
Figure 2
Figure 2
Correlations. A: Between hepatitis C viremia and CD83. r = -0.98, P < 0.001, CD86: r = -0.866, P < 0.001, CD40: r = -0.98, P < 0.001, PD-L1: r = 0.889, P < 0.001; B: Between hepatitis C viremia in uremic patients on hemodialysis and CD83. r = -0.096, P > 0.05 NS, CD86: r = -0.588, P < 0.05, CD40: r = -0.946, P < 0.001, PD-L1: r = 0.663, P < 0.05. HCV: Hepatitis C virus; DC: Dendritic cell
Figure 3
Figure 3
Serum levels of hyaluronic acid (ng/mL) and interleukin-10 (pg/mL) in all study subjects expressed as mean ± SD. aP < 0.05 vs control group, cP < 0.05 in the hepatitis C virus (HCV) patient group vs HCV uremic patients on hemodialysis. IL-10: Interleukin-10.
Figure 4
Figure 4
Correlation analysis. A: Between hyaluronic acid levels and hepatitis activity score (P < 0.001); B: Between hyaluronic acid levels and fibrosis score (P < 0.001); C: Between interleukin-10 (IL-10) levels and fibrosis score (P < 0.001).
See this image and copyright information in PMC

References

    1. Khan S, Attaullah S, Ali I, Ayaz S, Naseemullah SN, Siraj S, Khan J. Rising burden of Hepatitis C Virus in hemodialysis patients. Virol J. 2011;8:438. - PMC - PubMed
    1. Guerra J, Garenne M, Mohamed MK, Fontanet A. HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat. 2012;19:560–567. - PubMed
    1. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011;31 Suppl 2:61–80. - PubMed
    1. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci USA. 2010;107:14757–14762. - PMC - PubMed
    1. Khodir SA, Alghateb M, Okasha KM, Shalaby Sel-S. Prevalence of HCV infections among hemodialysis patients in Al Gharbiyah Governorate, Egypt. Arab J Nephrol Transplant. 2012;5:145–147. - PubMed

MeSH terms